Day Return
YTD Return
1-Year Return
3-Year Return
5-Year Return
Note: Sector performance is calculated based on the previous closing price of all sector constituents
Industries in This Sector
Select an Industry for a Visual Breakdown
| Industry | Market Weight | YTD Return | |
|---|---|---|---|
| All Industries | 100.00% | 7.94% | |
| Drug Manufacturers - General | 34.37% | 14.89% | |
| Healthcare Plans | 13.30% | 0.07% | |
| Medical Devices | 12.12% | 3.02% | |
| Biotechnology | 12.02% | 5.72% | |
| Diagnostics & Research | 11.12% | 5.04% | |
| Medical Instruments & Supplies | 6.77% | 10.28% | |
| Medical Care Facilities | 3.09% | 22.97% | |
| Drug Manufacturers - Specialty & Generic | 2.73% | -1.68% | |
| Medical Distribution | 2.30% | 10.92% | |
| Health Information Services | 2.04% | 8.33% | |
| Pharmaceutical Retailers | 0.15% | -56.61% | |
Note: Percentage % data on heatmap indicates Day Return
All Industries
--
<= -3
-2
-1
0
1
2
>= 3
Largest Companies in This Sector
View MoreName | Last Price | 1Y Target Est. | Market Weight | Market Cap | Day Change % | YTD Return | Avg. Analyst Rating |
|---|---|---|---|---|---|---|---|
| 859.88 | 917.64 | 11.48% | Buy | ||||
| 559.75 | 616.08 | 7.64% | Buy | ||||
| 156.28 | 171.47 | 5.58% | Buy | ||||
| 125.92 | 143.28 | 4.73% | Buy | ||||
| 176.21 | 186.08 | 4.61% | Buy | ||||
| 574.73 | 624.92 | 3.25% | Buy | ||||
| 265.76 | 280.29 | 2.85% | Buy | ||||
| 107.26 | 124.47 | 2.77% | Buy | ||||
| 335.61 | 320.24 | 2.67% | Buy | ||||
| 29.98 | 31.73 | 2.52% | Hold |
Investing in the Healthcare Sector
Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds
ETF Opportunities
View MoreName | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| 149.87 | 39.084B | 0.09% | ||
| 274.75 | 20.601B | 0.10% | ||
| 145.65 | 7.363B | 0.45% | ||
| 99.04 | 7.126B | 0.35% | ||
| 57.04 | 5.134B | 0.40% |
Mutual Fund Opportunities
View MoreName | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| 226.31 | 47.799B | 0.30% | ||
| 95.43 | 47.799B | 0.30% | ||
| 137.47 | 20.601B | 0.10% | ||
| 98.30 | 14.902B | 0.80% | ||
| 97.99 | 14.902B | 0.80% |
Healthcare Research
View MoreDiscover the Latest Analyst and Technical Research for This Sector
Analyst Report: AMN Healthcare Services, Inc.
AMN Healthcare Services is one of the largest healthcare staffing company in the United States. In 2023, it offered more than 13,000 nurses and allied healthcare full-time workers with provider clients nationwide. About two thirds of its business is generated from its temporary nursing division; the other third is generated from its physician placement and technology-backed workplace solutions divisions.
RatingPrice TargetAnalyst Report: Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the U.S. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market which B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
RatingPrice TargetAnalyst Report: Tenet Healthcare Corporation
Tenet Healthcare is a Dallas-based healthcare services organization. It operates a collection of hospitals (about 50 as of July 2024) and over 500 ambulatory surgery centers and other outpatient facilities across the U.S., primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
RatingPrice TargetAnalyst Report: Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
RatingPrice Target





















